Meanwhile, the oHSV expressing cytokine IL-12, and chemokine CCL5 as well as checkpoint inhibitor anti-PD-1 antibody, further augment CAR T cell trafficking to the tumor site and their antitumor activities. The gene discussed is CCL5; the disease is neoplasm.